Business · 04/09/1996Updated: 10/18/2026 · 1 min read
FDA Announces Meeting of Clinical Hold Review Committee for Investigational Biological Products
Summary
The FDA is hosting a meeting of its clinical hold review committee to review clinical hold orders on investigational biological product trials, and is inviting biological product companies to submit trials for review via a confidential mechanism.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →